Table 2.
n (%) | |
---|---|
ACTG staging | |
Tumor | |
0 | 29 (67) |
1 | 14 (33) |
Immune | |
0 | 3 (7) |
1 | 40 (93) |
System | |
0 | 11 (26) |
1 | 32 (74) |
Location of KS | |
Skin | 32 (74) |
Lung | 18 (42) |
GI | 15 (35) |
Lymphatic | 12 (28) |
Oral | 9 (21) |
Liver, spleen, or kidney | 3 (7) |
Bone | 2 (5) |
Number of organ systems involved | |
1 | 14 (33) |
2 | 14 (33) |
3+ | 15 (35) |
ACTG, AIDS clinical trial group.